Literature DB >> 25182012

Hypertrophic cardiomyopathy: a new mutation illustrates the need for family-centered care.

Daniel D Lee1, Regan L Veith, David P Dimmock, Margaret M Samyn.   

Abstract

This is a case series of a family positive for a previously undescribed mutation in the myofilament gene MYH7, causing hypertrophic cardiomyopathy (HCM), a potentially lethal cardiac disease with strong hereditability. The family's significant disease became strikingly apparent with the unanticipated diagnosis of their newborn infant shortly after her birth. This led to the discovery of the MYH7 mutation in the infant, as well as her father and two siblings, all of whom had varying degrees of disease severity. Despite prior diagnosis of HCM for the paternal grandmother and great uncles, this family's situation points to the need for continued education of healthcare providers, when heritable diseases are encountered. Genetics consult should occur early and has been shown to be helpful in making an accurate diagnosis and identifying relatives at risk of developing the condition. It may, as in this case series, lead to the discovery of a novel mutation and contribute to the growing genetic database for familial HCM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25182012     DOI: 10.1007/s00246-014-1002-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

Review 1.  Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.

Authors:  Michael P Frenneaux
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

2.  Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.

Authors:  Stephan Waldmüller; Jeanette Erdmann; Priska Binner; Götz Gelbrich; Sabine Pankuweit; Christian Geier; Bernd Timmermann; Janine Haremza; Andreas Perrot; Steffen Scheer; Rolf Wachter; Norbert Schulze-Waltrup; Anastassia Dermintzoglou; Jost Schönberger; Wolfgang Zeh; Beate Jurmann; Turgut Brodherr; Jan Börgel; Martin Farr; Hendrik Milting; Wulf Blankenfeldt; Richard Reinhardt; Cemil Özcelik; Karl-Josef Osterziel; Markus Loeffler; Bernhard Maisch; Vera Regitz-Zagrosek; Heribert Schunkert; Thomas Scheffold
Journal:  Eur J Heart Fail       Date:  2011-07-12       Impact factor: 15.534

Review 3.  Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.

Authors:  J Martijn Bos; Jeffrey A Towbin; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

4.  One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.

Authors:  Lotte Hougs; Ole Havndrup; Henning Bundgaard; Lars Køber; Jens Vuust; Lars Allan Larsen; Michael Christiansen; Paal Skytt Andersen
Journal:  Eur J Hum Genet       Date:  2005-02       Impact factor: 4.246

5.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.

Authors:  A Selcuk Adabag; Barry J Maron; Evan Appelbaum; Caitlin J Harrigan; Jacqueline L Buros; C Michael Gibson; John R Lesser; Constance A Hanna; James E Udelson; Warren J Manning; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

6.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.